PRRT (Peptide Receptor Radionuclide Therapy)
BELFAST HEALTH AND SOCIAL CARE TRUSTcontractFind a Tender ↗Ref ocds-h6vhtk-05dd8bProcurement Act 2023pending
Estimated value
—
Awarded value
£1.8m
Awarded 10 Nov 2025
Suppliers
1
Lots
1
1 awarded
Published
10 Nov 2025
Description
Procurement of PRRT (Peptide Receptor Radionuclide Therapy)
Scope
- Reference
- DAC
- Commercial tool
- Standalone contract
Submission & procedure
- Procedure
- Direct award
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£1.8m
Award date
10 Nov 2025
Contract start
20 Nov 2025
Contract end
31 Dec 2026
Awarded to
NP
CH 00119006
Awarded suppliers· 1 supplier
Awarded 10 Nov 2025 · Contract period 20 Nov 2025 — 31 Dec 2026
Award value
£1.8m
Other contracts from BELFAST HEALTH AND SOCIAL CARE TRUST
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to NOVARTIS PHARMACEUTICALS UK LIMITED· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| REVOLADE (ELTROMBOPAG) TABLETS, 28 tablet | contract | — | 07 Jul 2026 |
| Utathera 7400MBq/20.5-25ml solution | contract | — | 30 Jun 2026 |
| REVOLADE (ELTROMBOPAG) TABLETS, 28 tablet | contract | — | 17 Jun 2026 |
| Transitional Drugs 7 | contract | — | 05 Jun 2026 |
| TRAMETINIB 2MG TABLETS, 30 tablet, pack, PACK OF 1 | contract | — | 05 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| Generic, Branded Generic & Proprietary Medicinal Products - Group 17 | contract | — | 12 Jan 2026 |
| NHS National Framework Agreement for Omalizumab | contract | — | 30 Dec 2025 |
| NHS National Framework for Generics Housekeeping | contract | — | 22 Dec 2025 |
| Contract for Netspot (Gallium Ga 68 Dotatate) | contract | — | 08 Dec 2025 |